Searched for
DRDO COVID DRUG
Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DGDeveloped by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct therapy in mode...- DRDO to get 2 per cent royalty from Dr Reddy's on sale of anti-Covid drug 2-DG in India: GovtThe Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...
- BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DGLast month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild t...
- Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institu...
- Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drugShares of Bajaj Healthcare surged 11 per cent in early trade on Thursday after the company received license from Defence Research and Devel...
- Dr. Reddy's Laboratories announces commercial launch of COVID-19 drug 2-DGIn the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand covera...
- Dr Reddy's announces commercial launch of COVID-19 drug 2-DGIn the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand covera...
- DRDO invites EoI to transfer technology of 2-DG drug for bulk productionAccording to the EoI document, applications should be submitted before June 17 through email. "The EoI submitted by industries will be scru...
- DRDO calls for EoI to transfer 2DG with more playersDisclosing this on Tuesday evening, the DRDO chairman Dr G Satheesh Reddy said the EoIs were called from the interested Indian pharmaceutic...
- DRDO issues directions on usage of anti-COVID drug 2-DGThe Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...
- Debate over allopathy, ayurveda of no use; both systems useful: NITI Member V K SaraswatThe Niti Aayog Member's remarks on allopathy and ayurveda comes against the backdrop of the Indian Medical Association (IMA) raising strong...
- DRDO's 2 DG not linked with PatanjaliThe indigenous Covid-19 drug developed by the Defence Research and Development Organisation (DRDO) is not connected with research done by P...
- DRDO's anti-COVID drug priced at Rs 990 per sachet; Centre, states to get discountsThe first batch of DRDO's anti-Covid-19 drug was released on May 17 by Defence Minister Rajnath Singh and health minister Dr Harsh Vardhan,...
- Government mulling roping in 3-4 more firms to ramp up DRDO COVID-19 drug production2-DG has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS), in collaboration with Dr Reddy's Laboratories,...
- Will examine data of 2-DG drug for adding it to national COVID treatment protocol: GovtNITI Aayog member (health) Dr V K Paul said Drugs Controller General of India has granted permission for emergency use of the drug after lo...
- Rajnath Singh, Harsh Vardhan release first batch of DRDO's anti-COVID drug 2-DGThe Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...
- Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients todayThe first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation o...
- DRDO developed 2-DG drug could be game-changer: Karnataka Health Minister Dr K SudhakarThe 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine...
- DRDO’s new oral drug to reduce dependence on oxygenThe Institute of Nuclear Medicine and Allied Sciences, a DRDO lab, worked in partnership with Dr Reddy’s Laboratories to develop the drug, ...
- DCGI approves anti-COVID drug developed by DRDO for emergency useAccording to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D...
Load More
